Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Pneumonia and Septic Shock.

Hang-Long LiYi-Kei TseChanchal ChandramouliNicole Wing-Lam HonChing-Lung CheungLok-Yee LamMeizhen WuJia-Yi HuangSi-Yeung YuKa-Lam LeungYue FeiQi FengQingwen RenBernard M Y CheungHung-Fat TseSubodh VermaCarolyn S P LamKai-Hang Yiu

Published in: The Journal of clinical endocrinology and metabolism (2022)

Among DM patients, SGLT2is reduced the risk of pneumonia and septic shock compared with placebo. Our findings should be viewed as hypothesis generating, with concepts requiring validation in future studies.

Keyphrases

septic shock
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
type diabetes
randomized controlled trial
metabolic syndrome
respiratory failure
community acquired pneumonia
phase iii
study protocol
extracorporeal membrane oxygenation
acute respiratory distress syndrome